Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and brain, eye and nerve development (ID 501, 513, 540), maintenance of normal brain function (ID 497, 501, 510, 513, 519, 521, 534, 540, 688, 1323, 1360, 4294), maintenance of normal vision (ID 508, 510, 513, 519, 529, 540, 688, 2905, 4294), maintenance of normal cardiac function (ID 510, 688, 1360), “maternal health; pregnancy and nursing” (ID 514), “to fulfil increased omega-3 fatty acids need during pregnancy” (ID 539), “skin and digestive tract epithelial cells maintenance” (ID 525), enhancement of mood (ID 536), “membranes cell structure” (ID 4295), “anti-inflammatory action” (ID 4688) and maintenance of normal blood LDL-cholesterol concentrations (ID 4719) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Tabs

Article
Panel on Dietetic Products, Nutrition and Allergies
EFSA Journal
EFSA Journal 2011;9(4):2078 [30 pp.].
doi
10.2903/j.efsa.2011.2078
Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen.
Acknowledgements

The Panel wishes to thank for the preparatory work on this scientific opinion: The members of the Working Group on Claims: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Marina Heinonen, Hannu Korhonen, Martinus Løvik, Ambroise Martin, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Inge Tetens, Hendrik van Loveren and Hans Verhagen. The members of the Claims Sub-Working Group on Mental/Nervous System: Jacques Rigo, Astrid Schloerscheidt, Barbara Stewart-Knox, Sean (J.J.) Strain, and Peter Willatts.

Contact
Type
Opinion of the Scientific Committee/Scientific Panel
On request from
European Commission
Question Number
EFSA-Q-2008-1284
EFSA-Q-2008-1288
EFSA-Q-2008-1295
EFSA-Q-2008-1297
EFSA-Q-2008-1300
EFSA-Q-2008-1301
EFSA-Q-2008-1306
EFSA-Q-2008-1308
EFSA-Q-2008-1312
EFSA-Q-2008-1316
EFSA-Q-2008-1321
EFSA-Q-2008-1323
EFSA-Q-2008-1326
EFSA-Q-2008-1327
EFSA-Q-2008-1475
EFSA-Q-2008-2060
EFSA-Q-2008-2097
EFSA-Q-2008-3638
EFSA-Q-2010-00247
EFSA-Q-2010-00248
EFSA-Q-2010-00641
EFSA-Q-2010-00672
Adopted
17 February 2011
Published in the EFSA Journal
8 April 2011
Affiliation
European Food Safety Authority (EFSA), Parma, Italy
Note
Abstract

No abstract available

Keywords
Docosahexaenoic acid, DHA, eicosapentaenoic acid, EPA, cardiac function, brain, vision, mood, LDL-cholesterol, health claims
Print on demand
Number of Pages
30